Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 4306 AL 4320

Pharmacological treatment of apathy in Lewy body disorders: A systematic review

Liu J, Cooper CA, Weintraub D, Dahodwala N.

Parkinsonism Relat Disord. 2019 Mar;60:14-24. doi: 10.1016/j.parkreldis.2018.11.002. Epub 2018 Nov 5.

Role of MCP-1 and CCR2 in alcohol neurotoxicity

Zhang K, Luo J.

Pharmacol Res. 2019 Jan;139:360-366. doi: 10.1016/j.phrs.2018.11.030. Epub 2018 Nov 22.

Immune system responses in Parkinson's disease: Early and dynamic

Tansey MG, Romero-Ramos M.

Eur J Neurosci. 2019 Feb;49(3):364-383. doi: 10.1111/ejn.14290. Epub 2018 Dec 10.

Paraquat exposure and Parkinson's disease: A systematic review and meta-analysis

Tangamornsuksan W, Lohitnavy O, Sruamsiri R, Chaiyakunapruk N, Norman Scholfield C, Reisfeld B, Lohitnavy M.

Arch Environ Occup Health. 2019;74(5):225-238. doi: 10.1080/19338244.2018.1492894. Epub 2018 Nov 25.

Auditory and visual hallucination prevalence in Parkinson's disease and dementia with Lewy bodies: a systematic review and meta-analysis

Eversfield CL, Orton LD.

Psychol Med. 2019 Oct;49(14):2342-2353. doi: 10.1017/S0033291718003161. Epub 2018 Nov 26.

Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease

Zhao L, Cheng X, Zhong C.

ACS Chem Neurosci. 2019 Feb 20;10(2):922-930. doi: 10.1021/acschemneuro.8b00450. Epub 2018 Dec 12.

Information processing deficit in older adults with HIV infection: A comparison with Parkinson's disease

Sundaram S, Müller-Oehring EM, Fama R, Brontë-Stewart HM, Poston KL, Goodcase R, Martin T, Prabhakar V, Karpf J, Schulte T.

Neuropsychology. 2019 Feb;33(2):157-168. doi: 10.1037/neu0000500. Epub 2018 Nov 26.

The role of de novo mutations in adult-onset neurodegenerative disorders

Nicolas G, Veltman JA.

Acta Neuropathol. 2019 Feb;137(2):183-207. doi: 10.1007/s00401-018-1939-3. Epub 2018 Nov 26.

Exercise as a therapeutic intervention for motor and non-motor symptoms in Parkinson's disease: Evidence from rodent models

Crowley EK, Nolan YM, Sullivan AM.

Prog Neurobiol. 2019 Jan;172:2-22. doi: 10.1016/j.pneurobio.2018.11.003. Epub 2018 Nov 24.

The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors

Pajarillo E, Rizor A, Lee J, Aschner M, Lee E.

Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):1992-2000. doi: 10.1016/j.bbadis.2018.11.017. Epub 2018 Nov 24.

Cavernous Sinus Hemangioma: Surgical Aspects

Escudeiro GP, Leal RTM, Leal da Silveira R, Landeiro JA.

World Neurosurg. 2019 Mar;123:156. doi: 10.1016/j.wneu.2018.11.162. Epub 2018 Nov 24.

Vitamin D basis of Alzheimer's disease: from genetics to biomarkers

Dursun E, Gezen-Ak D.

Hormones (Athens). 2019 Mar;18(1):7-15. doi: 10.1007/s42000-018-0086-5. Epub 2018 Nov 27.

Serum soluble lymphocyte activation gene-3 as a diagnostic biomarker in Parkinson's disease: A pilot multicenter study

Cui SS, Du JJ, Liu SH, Meng J, Lin YQ, Li G, He YX, Zhang PC, Chen S, Wang G.

Mov Disord. 2019 Jan;34(1):138-141. doi: 10.1002/mds.27569. Epub 2018 Nov 28.

miR-34a in Neurophysiology and Neuropathology

Chua CEL, Tang BL.

J Mol Neurosci. 2019 Feb;67(2):235-246. doi: 10.1007/s12031-018-1231-y. Epub 2018 Nov 28.

Machine learning studies on major brain diseases: 5-year trends of 2014-2018

Sakai K, Yamada K.

Jpn J Radiol. 2019 Jan;37(1):34-72. doi: 10.1007/s11604-018-0794-4. Epub 2018 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias